Press release
Clinical Grade Disinfectant Market Growth Industry Analysis & Forecast By 2030 | Clariant AG, BASF SE, Ecolab, Inc., Lanxess AG, Lonza Group, Solvay SA, Milliken & Company
Medical facilities' escalating expenditure on hygiene products will complement the market growth through the duration of forecast period (2020-2030). The year-on-year growth projection for clinical grade disinfectant market for 2020 is nearly 23% compared to the previous year of 2019. Countries such as the United States, Italy, France, Germany, and India will be the growth epicenters through the second quarter.
"Inorganic growth strategies such as partnerships among regional and top players will bode well for market through 2020," concludes Fact.MR.
Request PDF Sample of the 170-page report on the Clinical Grade Disinfectant Market- https://www.factmr.com/connectus/sample?flag=S&rep_id=4702
Key Takeaways of Clinical Grade Disinfectant Market Study
Greater availability of alcohols & aldehydes will propel their consumption with the segment capturing over 30% share in the overall market stack.
Direct sales channel will remain preferred method of distribution over the forecast period.
South Asia will witness double-digit CAGR through 2030 owing to proliferation of medical facilities in the region.
The clinical grade disinfectant market in Europe will generate over 1/3rd of total demand during the projection period.
Key Drivers
Past decade witnessed an increase in number of R&D centers across the globe which is a major contributor to market growth.
Rise in number of highly contagious viral diseases such as H1N1, and COVID-19 will bolster the growth of clinical grade disinfectant market.
Relatively low manufacturing cost of alcohol & aldehydes will boost the production of this segment in terms of formulation.
Stringent government policies on disinfecting and sterilizing medical facilities will fuel the demand for clinical grade disinfectants through 2030.
Key Impediments
The uncertainty surrounding the future of pandemic and post-pandemic scenario will lead to fluctuation in market growth.
Emerging players in the clinical grade disinfectant market will face challenges in their efforts aimed at expanding revenue share due to consolidated competitive landscape.
Anticipated Impact of COVID-19 on Clinical Grade Disinfectant Market
In the wake of COVID-19 outbreak, healthcare facilities are driving the consumption of clinical grade disinfectants. As hospitals continue to be overwhelmed by COVID-19 patients, the demand for clinical grade disinfectants is projected to soar through the second quarter. Supply chain disruption and limited production capacity remain major challenges spurred by the pandemic. Therefore, major stakeholders continue to address these challenges through strategies such as partnerships, mergers and acquisitions, and capacity expansion. Further, increased government support for the production of clinical grade disinfectants amid COVID-19 pandemic will complement the market growth in foreseeable future.
Explore 96 tables and 96 figures of the study. Request ToC of the report at- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4702
Competition Landscape of Clinical Grade Disinfectant Market
The global clinical grade disinfectant market is highly consolidated in nature with top players occupying over 60% market share. Some of the key companies in the global clinical grade disinfectant market that are profiled in this Fact.MR study include but are not limited to, Lonza Group, BASF SE, Dow Chemical, Ecolab, Inc., Clariant AG, Microban International Limited, Milliken & Company, Solvay SA, Lanxess AG, DuPont, and Stepan Company.
While leading market players continue to look for ways for meeting the rapid surge in demand, emerging players are joining hands in the fight against COVID-19 as well. Hence, the clinical grade disinfectant market will witness the entry of new players aimed at leveraging the unprecedented demand. Moreover, established players such as Dow Chemical are expanding their production capacity. The company is now capable of producing 200 tons of isopropyl alcohol per week.
About the Report
This 170-page study offers in-depth commentary on the clinical grade disinfectant market. The study provides compelling insights on the clinical grade disinfectant market on the basis of formulation (quaternary ammonium compounds, chlorine compounds, alcoholds & aldehydes, and phenolic compounds), end user (hospitals, clinics, pathology labs, and research institutes), and sales channel (direct sales, online sales channel, and specialty stores) across seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).
Press Release: https://www.factmr.com/media-release/1451/global-clinical-grade-disinfectant-market
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Grade Disinfectant Market Growth Industry Analysis & Forecast By 2030 | Clariant AG, BASF SE, Ecolab, Inc., Lanxess AG, Lonza Group, Solvay SA, Milliken & Company here
News-ID: 2248242 • Views: …
More Releases from Fact.MR
USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Develo …
The U.S. microbiome skincare market is projected to experience rapid, data-driven growth over the next decade, driven by rising consumer awareness, ingredient innovation, and the integration of personalized diagnostics. Analysts estimate the U.S. microbiome skincare segment at approximately USD 0.13 billion in 2025, with a projected increase to USD 0.35 billion by 2035, representing a compound annual growth rate (CAGR) of 10.4%.
To access the complete data tables and in-depth insights,…
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future …
The U.S. lubricants market is projected to experience steady growth through 2035, driven by shifts in mobility, industrial demand, and sustainability trends. The market was valued at approximately $41.2 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $52 billion by 2035.
To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12463
…
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: K …
"Demand for intermodal freight transport connecting the UK and continental Europe is projected to grow at a CAGR of 6.8% between 2025 and 2035, driven by rising trade volumes, decarbonization mandates, and digital logistics innovations. The intermodal market, encompassing rail, short-sea shipping, and last-mile road delivery, is expected to handle over 18 million TEUs (twenty-foot equivalent units) annually by 2035, up from 10.2 million TEUs in 2025.
To access the complete…
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Fut …
The United States hydroxyapatite (HAp) market is projected to experience sustained, data-driven growth from 2025 through 2035, fueled by rising clinical demand, technological innovation, and expanded applications in regenerative medicine. Market modeling indicates that U.S. consumption of hydroxyapatite will nearly double over the next decade, with strong adoption in orthopedic, dental, and advanced biomaterial sectors.
To access the complete data tables and in-depth insights, request a Discount On The Report here:…
More Releases for Clinical
Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions.
Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,…
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction
The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary…
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes.
Market Size and Growth
The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion…
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical…
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
This is the premier interdisciplinary forum for…
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.
The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical…
